Program Book - Confex

More documents

Recommendations

Info

EXHIBITORS Lippincott, Williams and Wilkins Publisher Booth # 1100 www.lww.com Lupus Initiative, The Nonprofit Organization Booth # 733 www.thelupusinitiative.org McKesson Specialty Care Solutions Distributor Booth # 928 www.mckesson.com MedImmune, LLC Biotech Booth # 967 www.medimmune.com Merck Pharmaceuticals Booth # 1001 www.merck.com Merit Foundation Nonprofit Organization Booth # 129 www.meteorfoundation.com Metro Medical Supply Pharmacy Services Booth # 531 metromedical.com Metroplex Clinical Research Center Other Booth # 844 www.mcrcdallas.com National Data Bank for Rheumatic Diseases Nonprofit Organization Booth # 243 www.arthritis-research.org National Institute of Arthritis and Musculoskeletal and Skin Diseases Other: Government Booth # 233 www.niams.nih.gov New Balance Athletic Shoe, Inc. Other: Footwear Booth # 1017 www.newbalance.com Novartis Pharmaceuticals Corporation Pharmaceuticals Booth # 314 www.novartis.com Nutramax Laboratories, Inc. Nutritional Products Booth # 619 www.nutramaxlabs.com NYU Hospital for Joint Diseases Nonprofit Organization Booth # 234 www.med.nyu.edu/medicine/rheumatology Ochsner Health System Recruitment Booth # 1204 www.ochsner.org Optasia Medical, Inc Diagnostic Equipment/Products Booth # 1003 www.optasiamedical.com Organization of Teratology Information Specialists Nonprofit Organization Booth # 142 www.otispregnancy.org Ossur Americas Medical Device Booth # 729 www.Össur.com Oxford Immunotec Inc Diagnostic Products Booth # 108 www.oxfordimmunotec.com Oxford University Press Publisher Booth # 716 www.oxfordjournals.org Pan American League of Associations for Rheumatology (PANLAR) Non-profit Organization Booth # 228 www.Panlar.org PBL InterferonSource Contract Research, Laboratory Equipment/ Products Booth # 634 www.interferonsource.com Pfizer, Inc. Pharmaceuticals Booth # 401, 514, 913 www.pfizer.com Purdue Pharma L.P. Pharmaceuticals Booth # 1045 www.purduepharma.com Quidel Corporation Diagnostic Equipment/Products Booth # 1109 www.quidel.com R. J. Fasenmyer Center for Clinical Immunology Nonprofit Organization Booth # 140 www.clevelandclinic.org/FasenmyerCenter RDL Reference Laboratory Diagnostic Products Booth # 527 www.rdlinc.com Regeneron Pharmaceuticals, Inc. Pharmaceuticals Booth # 433 www.regeneron.com Replay Cafe Booth # 180 ReSearch Pharmaceutical Services Contract Research Booth # 738 www.rpsweb.com Rheumatoid Health Network Educational Materials for Patients Booth # 520 rheumatoidhealthnetwork.com Rheumatology News Publisher Booth # 712 www.rheumatologynews.com Rheumatology Nurses Society Nonprofit Organization Booth # 143 www.rns-network.org Rheumatology Practice News Publisher Booth # 735 http://www.rheumatologypracticenews.com Rottapharm Ltd Pharmaceuticals Booth # 728 www.rotta.com 318 2011 Program Book
EXHIBITORS Savient Pharmaceuticals Biotech Booth # 1056 www.Savientpharma.com Scandinavian Journal of Rheumatology Nonprofit Organization Booth # 240 www.scandjrheumatol.dk Scleroderma Foundation Nonprofit Organization Booth # 231 www.scleroderma.org Siemens Medical Solutions USA Inc. Diagnostic Equipment/Products Booth # 633 www.usa.siemens.com/rheumatology Silver Ring Splint Company Medical Device Therapeutic/Patient Aid Products Booth # 714 www.SilverRingSplint.com Sjögren’s Syndrome Foundation Nonprofit Organization Booth # 235 www.sjogrens.org Smith & Nephew Pharmaceuticals Booth # 849 www.smithnephew.com/us/professionals SonoSite Diagnostic Equipment/Products, Medical Device Booth # 1157 www.sonosite.com Spondylitis Association of America Nonprofit Organization, Educational Materials for Patients, Therapeutic/Patient Aid Products Booth # 229 www.spondylitis.org STOP Foodborne Illness Nonprofit Organization Booth # 338 www.stopfoodborneillness.org Swedish Orphan Biovitrum Pharmaceuticals Booth # 773 www.sobi.com Takeda Pharmaceuticals Pharmaceuticals Booth # 481 www.tpna.com Terason Diagnostic Equipment/Products, Medical Device Booth # 732 www.terason.com The Binding Site Laboratory Equipment/Products Booth # 1007 www.thebindingsite.com TheraTest Laboratories, Inc. Diagnostic Equipment/Products Booth # 949 www.theratest.com UpToDate Publisher Booth # 828 www.uptodate.com URL Pharma Pharmaceuticals Booth # 571 www.urlpharma.com Vasculitis Foundation Nonprofit Organization Booth # 135 www.vasculitisfoundation.org Vindico Medical Education Publisher Booth # 1005 www.VindicoMedEd.com Virtual Scopics Contract Research Booth # 865 www.virtualscopics.com Vitamin Health Nutritional Products Booth # 632 www.neoflex.com VQ OrthoCare Medical Device Booth # 333 www.vqorthocare.com Wiley Blackwell Publisher Booth # 1105 www.wiley.com 2011 Program Book 319
Page 1 and 2:
program B O O K Pre-Conference Cour
Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
Page 5 and 6:
TABLE OF CONTENTS POLICIES Copyrigh
Page 7 and 8:
TABLE OF CONTENTS ACR Immunology Up
Page 9 and 10:
TABLE OF CONTENTS Vasculitis Poster
Page 11 and 12:
However, the ACR continues to requi
Page 13 and 14:
MEETING NAVIGATION GUIDE To navigat
Page 15 and 16:
Newsroom Located in room W175c, use
Page 17:
Guided Poster Tours Guided poster t
Page 20 and 21:
FRIDAY November 4, 2011 9:15 am Ult
Page 22 and 23:
SATURDAY, NOVEMBER 5, 2011 12:00 -
Page 24 and 25:
SATURDAY November 5, 2011 8:35 am T
Page 26 and 27:
SATURDAY November 5, 2011 Pain: Pat
Page 28 and 29:
SUNDAY November 6, 2011 SUNDAY, NOV
Page 30 and 31:
SUNDAY November 6, 2011 Upon comple
Page 32 and 33:
EXHIBITS 10:00 am - 5:00 pm INNOVAT
Page 34 and 35:
SUNDAY November 6, 2011 ARHP SPECIA
Page 36 and 37:
SUNDAY November 6, 2011 W179b Rheum
Page 38 and 39:
3:15 pm 732. Notch Signaling Pathwa
Page 40 and 41:
SUNDAY November 6, 2011 3:15 pm 756
Page 42 and 43:
SUNDAY November 6, 2011 Children’
Page 44 and 45:
Page 46 and 47:
3:30 pm Demonstration and Practice
Page 48 and 49:
Yasser M. El Miedany 1 , Maha El Ga
Page 50 and 51:
SUNDAY November 6, 2011 48 Musculos
Page 52 and 53:
Page 54 and 55:
SUNDAY November 6, 2011 52 4:55 pm
Page 56 and 57:
MONDAY, NOVEMBER 7, 2011 ACR/ARHP R
Page 58 and 59:
MONDAY November 7, 2011 W185a Scler
Page 60 and 61:
MONDAY November 7, 2011 Upon comple
Page 62 and 63:
Upon completion of this session, pa
Page 64 and 65:
MONDAY November 7, 2011 W187b Basic
Page 66 and 67:
MONDAY November 7, 2011 2:30 pm Cel
Page 68 and 69:
MONDAY November 7, 2011 Indianapoli
Page 70 and 71:
3:45 pm 1628. Association of Knee P
Page 72 and 73:
MONDAY November 7, 2011 Glostrup, C
Page 74 and 75:
MONDAY November 7, 2011 3:33 pm A R
Page 76 and 77:
MONDAY November 7, 2011 4:30 pm Ris
Page 78 and 79:
Institutet, Stockholm, Sweden, 6 Un
Page 80 and 81:
5:45 pm 1700. Successful Dose De-Es
Page 82 and 83:
MONDAY November 7, 2011 Michigan, A
Page 84 and 85:
MONDAY November 7, 2011 4:45 pm 172
Page 86 and 87:
MONDAY November 7, 2011 5:25 pm Imp
Page 88 and 89:
TUESDAY November 8, 2011 ARHP CONCU
Page 90 and 91:
TUESDAY November 8, 2011 9:25 am Is
Page 92 and 93:
ACR PRACTICE ISSUE 9:30 - 10:30 am
Page 94 and 95:
TUESDAY November 8, 2011 noon 2431.
Page 96 and 97:
TUESDAY November 8, 2011 W186b Vasc
Page 98 and 99:
ACR CLINICAL SYMPOSIA 2:30 - 4:00 p
Page 100 and 101:
TUESDAY November 8, 2011 3:45 pm 24
Page 102 and 103:
TUESDAY November 8, 2011 University
Page 104 and 105:
TUESDAY November 8, 2011 and Oncolo
Page 106 and 107:
Italy, 3 Hospital Universitario La
Page 108 and 109:
3:10 pm Case Study Diane V. Lacaill
Page 110 and 111:
• discuss the evidence to support
Page 112 and 113:
TUESDAY November 8, 2011 4:45 pm 25
Page 114 and 115:
5:15 pm 2532. Selection of Patients
Page 116 and 117:
TUESDAY November 8, 2011 ACR/ARHP C
Page 118 and 119:
WEDNESDAY, NOVEMBER 9, 2011 ACR/ARH
Page 120 and 121:
9:00 am Mechanisms of Thrombosis in
Page 122 and 123:
WEDNESDAY November 9, 2011 A. Kopec
Page 124 and 125:
WEDNESDAY November 9, 2011 9:15 am
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
WEDNESDAY November 9, 2011 Graduate
Page 132 and 133:
11:00 am The Process: Defining Appr
Page 134 and 135:
ACR Poster Session A 11. Myocardial
Page 136 and 137:
ACR Poster Session A 37. Regulation
Page 138 and 139:
ACR Poster Session A 64. Interleuki
Page 140 and 141:
ACR Poster Session A Mexico City, M
Page 142 and 143:
ACR Poster Session A 121. An Analys
Page 144 and 145:
ACR Poster Session A 146. National
Page 146 and 147:
ACR Poster Session A 165. Genome-Wi
Page 148 and 149:
ACR Poster Session A 185. US Examin
Page 150 and 151:
ACR Poster Session A Jones 1 , Andr
Page 152 and 153:
ACR Poster Session A Gerald J. D. H
Page 154 and 155:
ACR Poster Session A 258. Etanercep
Page 156 and 157:
ACR Poster Session A GA, 6 Hospital
Page 158 and 159:
ACR Poster Session A 305. Pathway-B
Page 160 and 161:
ACR Poster Session A 328. Near Miss
Page 162 and 163:
ACR Poster Session A 351. A Novel M
Page 164 and 165:
ACR Poster Session A Sugihara 6 , K
Page 166 and 167:
ACR Poster Session A 398. Rituximab
Page 168 and 169:
ACR Poster Session A & Johnson Phar
Page 170 and 171:
ACR Poster Session A 436. Predicted
Page 172 and 173:
ACR Poster Session A Tomomi Tsuru 1
Page 174 and 175:
ACR Poster Session A 479. Follow up
Page 176 and 177:
ACR Poster Session A 496. A Chimeri
Page 178 and 179:
ACR Poster Session A 518. Associati
Page 180 and 181:
ACR Poster Session A Piestany, Slov
Page 182 and 183:
ACR Poster Session A 576. Fn14 Defi
Page 184 and 185:
ACR Poster Session A 593. Plasma Le
Page 186 and 187:
ACR Poster Session A 611. Why Do Lu
Page 188 and 189:
ACR Poster Session A 634. Associati
Page 190 and 191:
ACR Poster Session A Alarcon-Riquel
Page 192 and 193:
ACR Poster Session A Laboratories,
Page 194 and 195:
ACR Poster Session A Movsisyan, Lid
Page 196 and 197:
ACR Poster Session A Th1 Cells Expa
Page 198 and 199:
ACR/ARHP Poster Session B College o
Page 200 and 201:
ACR/ARHP Poster Session B 920. Econ
Page 202 and 203:
ACR/ARHP Poster Session B Study. A.
Page 204 and 205:
ACR/ARHP Poster Session B 974. Dise
Page 206 and 207:
ACR/ARHP Poster Session B 1001. Mic
Page 208 and 209:
ACR/ARHP Poster Session B 206 Khann
Page 210 and 211:
ACR/ARHP Poster Session B 208 Pulmo
Page 212 and 213:
ACR/ARHP Poster Session B Swearinge
Page 214 and 215:
ACR/ARHP Poster Session B 212 Felds
Page 216 and 217:
ACR/ARHP Poster Session B 214 Corbi
Page 218 and 219:
ACR/ARHP Poster Session B 1161. End
Page 220 and 221:
ACR/ARHP Poster Session B 1182. Uri
Page 222 and 223:
ACR/ARHP Poster Session B 1205. A S
Page 224 and 225:
ACR/ARHP Poster Session B 222 Murth
Page 226 and 227:
ACR/ARHP Poster Session B San Diego
Page 228 and 229:
ACR/ARHP Poster Session B 1266. Eva
Page 230 and 231:
ACR/ARHP Poster Session B 1296. Pat
Page 232 and 233:
ACR/ARHP Poster Session B 230 1320.
Page 234 and 235:
ACR/ARHP Poster Session B 1348. Syn
Page 236 and 237:
ACR/ARHP Poster Session B 1375. Ant
Page 238 and 239:
ACR/ARHP Poster Session B 1398. Cli
Page 240 and 241:
ACR/ARHP Poster Session B Baltimore
Page 242 and 243:
ACR/ARHP Poster Session B 1451. Ele
Page 244 and 245:
ACR/ARHP Poster Session B Sclerosis
Page 246 and 247:
ACR/ARHP Poster Session B 1496. Evi
Page 248 and 249:
ACR/ARHP Poster Session B 1518. Pro
Page 250 and 251:
ACR/ARHP Poster Session B Hagen 1 ,
Page 252 and 253:
ACR/ARHP Poster Session B ARHP Clin
Page 254 and 255:
ACR/ARHP Poster Session C Karl Eger
Page 256 and 257:
ACR/ARHP Poster Session C Tampere S
Page 258 and 259:
ACR/ARHP Poster Session C 256 1 Jun
Page 260 and 261:
ACR/ARHP Poster Session C Universit
Page 262 and 263:
ACR/ARHP Poster Session C 1864. Epi
Page 264 and 265:
ACR/ARHP Poster Session C 262 Hospi
Page 266 and 267:
ACR/ARHP Poster Session C 2 Biogen
Page 268 and 269:
ACR/ARHP Poster Session C 1945. Cir
Page 270 and 271: ACR/ARHP Poster Session C 268 1974.
Page 272 and 273: ACR/ARHP Poster Session C 2003. Eff
Page 274 and 275: ACR/ARHP Poster Session C Hosp Gast
Page 276 and 277: ACR/ARHP Poster Session C Toronto,
Page 278 and 279: ACR/ARHP Poster Session C Francisco
Page 280 and 281: ACR/ARHP Poster Session C 2105. Inc
Page 282 and 283: ACR/ARHP Poster Session C Universit
Page 290 and 291: ACR/ARHP Poster Session C 2217. Lon
Page 292 and 293: ACR/ARHP Poster Session C Research
Page 294 and 295: ACR/ARHP Poster Session C 2258. sIL
Page 296 and 297: ACR/ARHP Poster Session C 2290. The
Page 298 and 299: ACR/ARHP Poster Session C Universit
Page 300 and 301: ACR/ARHP Poster Session C 2345. IL-
Page 302 and 303: ACR/ARHP Poster Session C 2376. Gra
Page 304 and 305: ACR/ARHP Poster Session C 2399. Spe
Page 306 and 307: REF Industry Roundtable-supported S
Page 308 and 309: REF Industry Roundtable-supported S
Page 310 and 311: Industry-supported POST-CONFERENCE
Page 312 and 313: CERTIFICATES OF CME CREDIT OR PARTI
Page 314 and 315: 2011 ACR/ARHP Annual Meeting Leader
Page 316 and 317: 2011 ACR/ARHP Annual Meeting Leader
Page 318 and 319: EXHIBITORS Abbott Pharmaceuticals B
Page 322 and 323: acknowledgements The ACR, the ARHP
Page 324 and 325: Invited Speaker /Moderator Index 32
Page 328 and 329: Invited Speaker /Moderator Index Ev
Page 334 and 335: Invited Speaker /Moderator Index Mu
Page 336 and 337: Invited Speaker /Moderator Index Om
Page 338 and 339: Invited Speaker /Moderator Index St
Page 340 and 341: Invited Speaker /Moderator Index Wi
Page 342 and 343: aBSTRACT author Index 340 Alpers, C
Page 344 and 345: aBSTRACT author Index Bawa, WA 259
Page 346 and 347: aBSTRACT author Index 344 Broder, A
Page 348 and 349: aBSTRACT author Index 346 Chaves, L
Page 350 and 351: aBSTRACT author Index 348 Dalbeth,
Page 352 and 353: aBSTRACT author Index Eastman, PS 3
Page 354 and 355: aBSTRACT author Index 352 Fragoso-L
Page 356 and 357: aBSTRACT author Index Gordon, C 4,
Page 358 and 359: aBSTRACT author Index Hemmati, I 13
Page 360 and 361: aBSTRACT author Index 358 Ishigatsu
Page 362 and 363: aBSTRACT author Index 360 Keeling,
Page 364 and 365: aBSTRACT author Index 362 Kumar, V
Page 366 and 367: aBSTRACT author Index 364 Lim, M 13
Page 368 and 369: aBSTRACT author Index 366 Marshall,
Page 370 and 371:
aBSTRACT author Index 368 MMF/AZA L
Page 372 and 373:
aBSTRACT author Index 370 Noel, D 1
Page 374 and 375:
aBSTRACT author Index 372 Pawlita,
Page 376 and 377:
aBSTRACT author Index 374 Ramos, I
Page 378 and 379:
aBSTRACT author Index 376 Rönnblom
Page 380 and 381:
aBSTRACT author Index 378 Shaykevic
Page 382 and 383:
aBSTRACT author Index Su, J 22, 139
Page 384 and 385:
aBSTRACT author Index 382 Tomcik, M
Page 386 and 387:
aBSTRACT author Index 384 Villeneuv
Page 388 and 389:
aBSTRACT author Index 386 Wu, X 650
Page 390 and 391:
abstract keyword Index 388 18FDG PE
Page 392 and 393:
abstract keyword Index 2092, 2113,
Page 394 and 395:
abstract keyword Index 392 macropha
Page 396 and 397:
abstract keyword Index 387, 388, 38
Page 398 and 399:
Abstract Moderator disclosure A Ano
Page 400 and 401:
Abstract Moderator disclosure Jonas
Page 402 and 403:
V van der Heijde, Desiree, MD, PhD
Page 404 and 405:
Notes 402 2011 Program Book
Page 406 and 407:
immunosuppressive agents is not rec
Page 408:
In appropriate patients with psoria
show all

Program Book - Confex

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?